2,831
Participants
Start Date
May 31, 2007
Primary Completion Date
August 31, 2007
Study Completion Date
February 29, 2008
Meningococcal ACWY Polysaccharide Vaccine
One dose of the licensed meningococcal ACWY polysaccharide vaccine was administered by subcutaneous injection.
MenACWY CRM (19 to 55 years)
One dose of the Novartis meningococcal ACWY conjugate vaccine was administered by intramuscular injection to subjects 19 years to 55 years of age.
Meningococcal ACWY Conjugate Vaccine
One dose of the licensed meningococcal ACWY polysaccharide-protein conjugate vaccine was administered by intramuscular injection.
Novartis MenACWY Vaccine (56 to 65 Years)
One dose of the Novartis meningococcal ACWY conjugate vaccine was administered by intramuscular injection administered to subjects 56 years to 65 years of age.
Buenos Aires, Argentina, Buenos Aires
Cali, Colombia; Bogota, Colombia, Cali; Bogota
Lead Sponsor
Novartis Vaccines
INDUSTRY